These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 18075302

  • 1. PDGF BB induces VEGF secretion in ovarian cancer.
    Matei D, Kelich S, Cao L, Menning N, Emerson RE, Rao J, Jeng MH, Sledge GW.
    Cancer Biol Ther; 2007 Dec; 6(12):1951-9. PubMed ID: 18075302
    [Abstract] [Full Text] [Related]

  • 2. Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation.
    Servidei T, Riccardi A, Sanguinetti M, Dominici C, Riccardi R.
    J Cell Physiol; 2006 Jul; 208(1):220-8. PubMed ID: 16575905
    [Abstract] [Full Text] [Related]

  • 3. Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation.
    Matei D, Chang DD, Jeng MH.
    Clin Cancer Res; 2004 Jan 15; 10(2):681-90. PubMed ID: 14760091
    [Abstract] [Full Text] [Related]

  • 4. Imatinib mesylate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB.
    Aoki M, Nabeshima K, Koga K, Hamasaki M, Suzumiya J, Tamura K, Iwasaki H.
    Lab Invest; 2007 Aug 15; 87(8):767-79. PubMed ID: 17558420
    [Abstract] [Full Text] [Related]

  • 5. Imatinib mesylate inhibits the proliferation-stimulating effect of human lung cancer-associated stromal fibroblasts on lung cancer cells.
    Kinoshita K, Nakagawa K, Hamada J, Hida Y, Tada M, Kondo S, Moriuchi T.
    Int J Oncol; 2010 Oct 15; 37(4):869-77. PubMed ID: 20811709
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.
    Hwang RF, Yokoi K, Bucana CD, Tsan R, Killion JJ, Evans DB, Fidler IJ.
    Clin Cancer Res; 2003 Dec 15; 9(17):6534-44. PubMed ID: 14695158
    [Abstract] [Full Text] [Related]

  • 7. Malignant transformation of human cells by constitutive expression of platelet-derived growth factor-BB.
    Govindarajan B, Shah A, Cohen C, Arnold RS, Schechner J, Chung J, Mercurio AM, Alani R, Ryu B, Fan CY, Cuezva JM, Martinez M, Arbiser JL.
    J Biol Chem; 2005 Apr 08; 280(14):13936-43. PubMed ID: 15695519
    [Abstract] [Full Text] [Related]

  • 8. Selective inhibition of PDGFR by imatinib elicits the sustained activation of ERK and downstream receptor signaling in malignant glioma cells.
    Dong Y, Jia L, Wang X, Tan X, Xu J, Deng Z, Jiang T, Rainov NG, Li B, Ren H.
    Int J Oncol; 2011 Feb 08; 38(2):555-69. PubMed ID: 21152856
    [Abstract] [Full Text] [Related]

  • 9. Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy.
    van Steensel L, Paridaens D, Schrijver B, Dingjan GM, van Daele PL, van Hagen PM, van den Bosch WA, Drexhage HA, Hooijkaas H, Dik WA.
    Invest Ophthalmol Vis Sci; 2009 Jul 08; 50(7):3091-8. PubMed ID: 19234339
    [Abstract] [Full Text] [Related]

  • 10. Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma.
    Kubo T, Piperdi S, Rosenblum J, Antonescu CR, Chen W, Kim HS, Huvos AG, Sowers R, Meyers PA, Healey JH, Gorlick R.
    Cancer; 2008 May 15; 112(10):2119-29. PubMed ID: 18338812
    [Abstract] [Full Text] [Related]

  • 11. Autocrine activation of PDGFRalpha promotes the progression of ovarian cancer.
    Matei D, Emerson RE, Lai YC, Baldridge LA, Rao J, Yiannoutsos C, Donner DD.
    Oncogene; 2006 Mar 30; 25(14):2060-9. PubMed ID: 16331269
    [Abstract] [Full Text] [Related]

  • 12. Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling.
    Hasumi Y, Kłosowska-Wardega A, Furuhashi M, Ostman A, Heldin CH, Hellberg C.
    Int J Cancer; 2007 Dec 15; 121(12):2606-14. PubMed ID: 17691110
    [Abstract] [Full Text] [Related]

  • 13. Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma.
    Kim R, Emi M, Arihiro K, Tanabe K, Uchida Y, Toge T.
    Cancer; 2005 May 01; 103(9):1800-9. PubMed ID: 15786421
    [Abstract] [Full Text] [Related]

  • 14. Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.
    Perros F, Montani D, Dorfmüller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, Mazmanian M, Fadel E, Mussot S, Mercier O, Hervé P, Emilie D, Eddahibi S, Simonneau G, Souza R, Humbert M.
    Am J Respir Crit Care Med; 2008 Jul 01; 178(1):81-8. PubMed ID: 18420966
    [Abstract] [Full Text] [Related]

  • 15. Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor.
    Abouantoun TJ, MacDonald TJ.
    Mol Cancer Ther; 2009 May 01; 8(5):1137-47. PubMed ID: 19417143
    [Abstract] [Full Text] [Related]

  • 16. Synergistic effects of imatinib and carboplatin on VEGF, PDGF and PDGF-Rα/ß expression in squamous cell carcinoma of the head and neck in vitro.
    Schultz JD, Rotunno S, Riedel F, Anders C, Erben P, Hofheinz RD, Faber A, Thorn C, Sommer JU, Hörmann K, Sauter A.
    Int J Oncol; 2011 Apr 01; 38(4):1001-12. PubMed ID: 21249316
    [Abstract] [Full Text] [Related]

  • 17. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.
    Pietras K, Pahler J, Bergers G, Hanahan D.
    PLoS Med; 2008 Jan 29; 5(1):e19. PubMed ID: 18232728
    [Abstract] [Full Text] [Related]

  • 18. Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.
    Uren A, Merchant MS, Sun CJ, Vitolo MI, Sun Y, Tsokos M, Illei PB, Ladanyi M, Passaniti A, Mackall C, Toretsky JA.
    Oncogene; 2003 Apr 17; 22(15):2334-42. PubMed ID: 12700668
    [Abstract] [Full Text] [Related]

  • 19. Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo.
    McGary EC, Onn A, Mills L, Heimberger A, Eton O, Thomas GW, Shtivelband M, Bar-Eli M.
    J Invest Dermatol; 2004 Feb 17; 122(2):400-5. PubMed ID: 15009722
    [Abstract] [Full Text] [Related]

  • 20. The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB.
    Shimizu A, O'Brien KP, Sjöblom T, Pietras K, Buchdunger E, Collins VP, Heldin CH, Dumanski JP, Ostman A.
    Cancer Res; 1999 Aug 01; 59(15):3719-23. PubMed ID: 10446987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.